A detailed history of Colonial Trust Advisors transactions in Novartis Ag stock. As of the latest transaction made, Colonial Trust Advisors holds 500 shares of NVS stock, worth $49,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$49,175
Previous $53,000 7.55%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $185 - $214
-2 Reduced 0.4%
500 $53,000
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $190 - $216
2 Added 0.4%
502 $48,000
Q4 2023

Feb 14, 2024

SELL
$92.27 - $101.54 $27,681 - $30,462
-300 Reduced 37.5%
500 $50,000
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $59,688 - $69,808
800 New
800 $61,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Colonial Trust Advisors Portfolio

Follow Colonial Trust Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.